Health Care & Life Sciences » Biotechnology | Epizyme Inc.

Epizyme Inc.

Epizyme Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 69.5 M
Public Float
 39.65 M
Epizyme Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $1.64
Market Cap
 $1.21 B
Shares Outstanding
 90.83 M
Public Float
 58.14 M

Profile

Address
400 Technology Square
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.epizyme.com
Updated 07/08/2019
Develops therapeutics for the treatment of patients with genetically defined cancers .

Financials

View All
Created with Highcharts 5.0.14Epizyme Inc.Net Income. Fiscal year is January-December. All values USD Thousands.3 4833 48355 00555 005132 376132 376110 212110 212134 309134 309123 630123 630201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Epizyme Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.68 48268 48241 41141 4112 5602 5608 0078 00710 00010 00021 70021 700201320142015201620172018020k40k60k80k

Robert B. Bazemore
President, Chief Executive Officer & Director
Michael F. Giordano
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.